Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase
Qing Li, Wei Hu, Weixin Liu, et al.
Gastroenterology (2020) Vol. 160, Iss. 4, pp. 1179-1193.e14
Closed Access | Times Cited: 179

Showing 26-50 of 179 citing articles:

Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
Yifeng Lin, Lina Fan, Yadong Qi, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 23
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
The Impact of the Gut Microbiome, Environment, and Diet in Early-Onset Colorectal Cancer Development
Rui Dai, Bridget N. Kelly, Amarachi Ike, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 676-676
Open Access | Times Cited: 14
Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase
Anthony Chin Yang Su, Xiao Ding, Harry Cheuk-Hay Lau, et al.
Gut (2024) Vol. 73, Iss. 9, pp. 1478-1488
Open Access | Times Cited: 14
Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
Chunhao Cao, Siran Yue, Aiping Lu, et al.
Pharmacological Research (2024) Vol. 207, pp. 107321-107321
Open Access | Times Cited: 12
Gut microbes in central nervous system development and related disorders
Yumeng Gan, Yao Chen, Huijie Zhong, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 10
A microbial metabolite inhibits the HIF-2α-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH
Yi Zhang, Xuemei Wang, Jun Lin, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1823-1838.e6
Closed Access | Times Cited: 10
The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives
Xuejiao Wei, Fei Wang, Peng Tan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107148-107148
Open Access | Times Cited: 8
Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria
Dai Lu, Xianxiong Ma, Kaixiong Tao, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 106-106
Open Access | Times Cited: 1
Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer
Hao Zhang, Yuan Tian, Chunjie Xu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Crosstalk between autophagy and microbiota in cancer progression
Yu Wang, Jiang Du, Xuemei Wu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences
Sofia C. Tortora, Vimal Bodiwala, Andrew Quinn, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 2, pp. 375-395
Open Access | Times Cited: 32
Cultivated human intestinal fungusCandida metapsilosisM2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists
Xiaokui Huo, Dawei Li, Fan Wu, et al.
Gut (2022) Vol. 71, Iss. 11, pp. 2205-2217
Closed Access | Times Cited: 30
Beneficial insights into postbiotics against colorectal cancer
Dingka Song, Xiuli Wang, Yongjing Ma, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 18
Metabolic Properties, Functional Characteristics, and Practical Application of Streptococcus thermophilus
Yanyan Huang, Yun‐hui Lu, Xintong Liu, et al.
Food Reviews International (2023) Vol. 40, Iss. 2, pp. 792-813
Closed Access | Times Cited: 16
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xiaoyu Xue, Rui Li, Zhenni Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Bifidobacterium longum suppresses colorectal cancer through the modulation of intestinal microbes and immune function
Fangjian Shang, Xia Jiang, Haobo Wang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Mong‐Hong Lee
Cancer Communications (2021) Vol. 41, Iss. 10, pp. 937-967
Open Access | Times Cited: 36
Intermittent fasting supports the balance of the gut microbiota composition
Hikmet Taner Teker, Taha Ceylani
International Microbiology (2022) Vol. 26, Iss. 1, pp. 51-57
Closed Access | Times Cited: 27
Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential “Next Generation Probiotic”
Chao Zhang, Kejia Ma, Kai Nie, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 24
Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine Production
Ning Ding, Yikun Cheng, Huijuan Liu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 13
Effect of gut flora mediated‐bile acid metabolism on intestinal immune microenvironment
Yan Zhang, Xueyan Gao, Shuochen Gao, et al.
Immunology (2023) Vol. 170, Iss. 3, pp. 301-318
Open Access | Times Cited: 13
Oral probiotics microgel plus Galunisertib reduced TGF-β blockade resistance and enhanced anti-tumor immune responses in colorectal cancer
Lili Niu, Yao Liu, Nannan Li, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123810-123810
Closed Access | Times Cited: 5
Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies
Niloofar Kiaheyrati, Abouzar Babaei, Reza Ranji, et al.
Life Sciences (2024) Vol. 349, pp. 122734-122734
Closed Access | Times Cited: 5
Fusobacterium species are distinctly associated with patients with Lynch syndrome colorectal cancer
Felix Salim, Sayaka Mizutani, Satoshi Shiba, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110181-110181
Open Access | Times Cited: 5

Scroll to top